Finally, to determine whether PXR down-regulation affected the in vivo tumor-initiating potential of Folfiri-resistant tumor cells, we subcutaneously transplanted 1,500 cells obtained from residual tumors collected three days after treatment completion (day 48) into new nude mice (Figure 6e). The gene discussed is NR1I2; the disease is neoplasm.